U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis complex
  1. Economic Impact Analyses of FDA Regulations

Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis complex

This rule proposes to reclassify nucleic acid-based in vitro diagnostic devices for the detection of M. tuberculosis complex from class II (pre-market approval or PMA) to class II (special controls). These devices are intended to be used as an aid in the diagnosis of pulmonary tuberculosis.

Regulatory Impact Analysis

Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis complex (PDF - 201KB)

Federal Register: 78 FR 36698-36702, June 19, 2013

Docket: FDA-2013-N-0559

   
 
Back to Top